SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-24-201347
Filing Date
2024-08-15
Accepted
2024-08-15 16:35:24
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 d876017df3.htm F-3 442707
2 EX-4.3 d876017dex43.htm EX-4.3 198463
3 EX-4.7 d876017dex47.htm EX-4.7 320258
4 EX-4.8 d876017dex48.htm EX-4.8 326328
5 EX-5.1 d876017dex51.htm EX-5.1 69620
6 EX-5.2 d876017dex52.htm EX-5.2 25984
7 EX-23.1 d876017dex231.htm EX-23.1 1671
8 EX-FILING FEES d876017dexfilingfees.htm EX-FILING FEES 49364
9 GRAPHIC g876017g0813102015535.jpg GRAPHIC 3685
10 GRAPHIC g876017g21a79.jpg GRAPHIC 10127
11 GRAPHIC g876017g34y35.jpg GRAPHIC 25195
  Complete submission text file 0001193125-24-201347.txt   1489648
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-281576 | Film No.: 241212950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)